Sadeghi, S., Groshen, S. G., Tsao-Wei, D. D., Parikh, R., Mortazavi, A., Dorff, T. B., . . . Lara Jr, P. N. (2019). Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653). J Clin Oncol.
Čikaški stil citiranjaSadeghi, Sarmad, et al. "Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)." J Clin Oncol 2019.
MLA način citiranjaSadeghi, Sarmad, et al. "Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)." J Clin Oncol 2019.